Shashank Srowthy to succeed Lokesh Chandak as CFO of P&G Health
Advertisement
Mumbai: Procter & Gamble Health Limited has appointed Shashank Srowthy as Chief Financial Officer (CFO) of the Company and Additional (Executive) Director effective October 1, 2025. His appointment is subject to the allotment of a Director Identification Number by the Ministry of Corporate Affairs.
Srowthy succeeds Lokesh Chandak, who will step down as Director & CFO effective close of business hours of September 30, 2025, as he will be moving onto his new assignment in P&G as Senior Director – Finance & Accounting, Feminine Care- Asia Pacific Enterprise Markets, Middle East and Africa.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.